Time in nature
What studies of time in nature found
At a glance, by condition
ME/CFS: C Might help, very uncertain
Based on the strongest evidence, studies with no comparison group (very low certainty): 4 of 5 findings are C.
5 outcomes rated · see each below
How we got this
Each condition’s headline comes from its graded findings (one for each outcome and kind of study) rated with the highest certainty: the grade most of them share; a tie goes to the finding with the most people, then the most studies, then the outcome’s name. It sums up the grades below, and conditions are never combined.
What this means: Time in nature might help some people with ME/CFS, but research can’t show it yet. If you’re thinking about it, talk it through with a doctor who knows ME/CFS or long COVID.
Ask about this treatment
The grades, in plain words
Each outcome gets a direction, a certainty and a letter read from the two. Certainty is judged with GRADE, the method Cochrane and WHO use.
- AHelpsImprovement, high certaintyProbably helpsImprovement, moderate certainty
- BMay helpImprovement, low certainty
- Time in nature · ME/CFS is hereCMight help, very uncertainImprovement, very low certaintyMixed resultsStudies disagree
- DLittle or no differenceStudies found little or no difference
- FHarmsIt made things worse
By symptom and daily life
ME/CFS
Anxiety1 study · 44 people tried time in nature Improvement C
Why this grade: Improvement, very low certainty, from studies without a control group: no control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design); few people (44 in all); the paper's own effect size: 1.31 (Cohen's d).
Studies with no comparison group44 in the study · in the first 24 h after the FB session · 3 km silence walk in 3 h, one session, with three 10 min stops
Anxiety improved.
The evidence is very uncertain about the effect of time in nature on anxiety in ME/CFS. Improvement · very low certainty C
- No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
- Few people (44 in all)
- The paper's own effect size: 1.31 (Cohen's d)
See the 1 study
-
- People in the study
- 44 in the study
- Dose
- 3 km silence walk in 3 h, one session, with three 10 min stops
- Outcome
- state anxiety State–Trait Anxiety Inventory—State
- Effect
- better
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Depression1 study · 44 people tried time in nature Improvement C
Why this grade: Improvement, very low certainty, from studies without a control group: no control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design); few people (44 in all); the paper's own effect size: 1.21 (Cohen's d).
Studies with no comparison group44 in the study · in the first 24 h after the FB session · 3 km silence walk in 3 h, one session, with three 10 min stops
Depression improved.
The evidence is very uncertain about the effect of time in nature on depression in ME/CFS. Improvement · very low certainty C
- No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
- Few people (44 in all)
- The paper's own effect size: 1.21 (Cohen's d)
See the 1 study
-
- People in the study
- 44 in the study
- Dose
- 3 km silence walk in 3 h, one session, with three 10 min stops
- Outcome
- depression Profile of Mood States
- Effect
- better
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Fatigue1 study · 44 people tried time in nature Improvement C
Why this grade: Improvement, very low certainty, from studies without a control group: no control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design); few people (44 in all); the paper's own effect size: 0.4 (Cohen's d).
Studies with no comparison group44 in the study · in the first 24 h after the FB session · 3 km silence walk in 3 h, one session, with three 10 min stops
Fatigue improved.
The evidence is very uncertain about the effect of time in nature on fatigue in ME/CFS. Improvement · very low certainty C
- No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
- Few people (44 in all)
- The paper's own effect size: 0.4 (Cohen's d)
See the 1 study
-
- People in the study
- 44 in the study
- Dose
- 3 km silence walk in 3 h, one session, with three 10 min stops
- Outcome
- fatigue Profile of Mood States
- Effect
- better
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Low mood or anxiety1 study · 44 people tried time in nature Improvement C
Why this grade: Improvement, very low certainty, from studies without a control group: no control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design); few people (44 in all); the paper's own effect size: 0.84 (Cohen's d).
Studies with no comparison group44 in the study · in the first 24 h after the FB session · 3 km silence walk in 3 h, one session, with three 10 min stops
Low mood or anxiety improved.
The evidence is very uncertain about the effect of time in nature on low mood or anxiety in ME/CFS. Improvement · very low certainty C
- No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
- Few people (44 in all)
- The paper's own effect size: 0.84 (Cohen's d)
See the 1 study
-
- People in the study
- 44 in the study
- Dose
- 3 km silence walk in 3 h, one session, with three 10 min stops
- Outcome
- negative affect Positive Affect and Negative Affect Scale
- Effect
- better
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Pain1 study · 44 people tried time in nature Little or no difference D
Why this grade: Little or no difference, very low certainty, from studies without a control group: no control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design); few people (44 in all).
Studies with no comparison group44 in the study · in the first 24 h after the FB session · 3 km silence walk in 3 h, one session, with three 10 min stops
No clear change in pain.
The evidence is very uncertain about the effect of time in nature on pain in ME/CFS. Little or no difference · very low certainty D
- No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
- Few people (44 in all)
See the 1 study
-
- People in the study
- 44 in the study
- Dose
- 3 km silence walk in 3 h, one session, with three 10 min stops
- Outcome
- pain intensity Visual Analog Scale for rating pain intensity in the present moment (VAS PAIN)
- Effect
- no clear difference
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Side effects
No study of this treatment alone reported side effects we could read.
All papers
- Mechanism of the Huangguoshu waterfall forest environment's promotive effect on human health in Guizhou, China.2022 · randomised trial · 32 randomised · 24 started · 24 analysed
Summary
The study aimed to investigate the mechanism of the Huangguoshu waterfall forest environment’s health-promoting effects. It recruited patients with chronic fatigue syndrome (CFS) diagnosed in psychology and psychiatric outpatient departments of the Affiliated Hospital of Guizhou Medical University and Guizhou Provincial People’s Hospital from January 2010 to January 2019. Among 32 patients with CFS aged 20 to 55 years, 24 were selected and divided into 2 groups of 12; a random number generator was used to assign numbers between 1 and 24. One group stayed in the Huangguoshu waterfall forest environment for 7 days; the other carried out activities in an urban landscape area with a routine workload. Follow-up was at baseline, 3 days, and 7 days. Outcomes included the Hamilton Anxiety Scale (HAMA), Hamilton Depression Scale (HAMD), FS-14 somatic and mental fatigue scales, and the paced auditory serial addition task (PASAT). Compared with the urban group, HAMA and HAMD scores in the waterfall group were significantly decreased after 7 days. FS-14 somatic fatigue was 3.66±0.98 in the waterfall group versus 5.50±0.80 in the urban group at day 7; mental fatigue was 2.66±0.78 versus 4.16±1.11 (P<0.05 or P<0.01). PASAT correct and attempt numbers increased after 7 days in the waterfall group, with significance not reported. The authors also report no significant difference in serum glucose, triglyceride, total cholesterol, and creatinine after 7 days. Side effects, withdrawals due to harms, and people who worsened or stopped were not reported.
- [NATURAL THERAPEUTIC FACTORS IN MEDICAL REHABILITATION OF PATIENTS WITH POST-COVID-19 AT OUTPATIENT TREATMENT STAGE].2021 · compared with another group · 64 in the study
Summary
This abstract reports a study at Nalchik resort of 64 patients with corona virus disease COVID-19 / Post-COVID-19 syndrome at outpatient treatment stage. Patients were allocated to a comparison group of 30 and a main group of 34. The comparison group received mineral water «Nalchik», exercise therapy, foam cocktails and rectal suppositories with thick licorice root extract. The main group additionally received natural aeroionophyto therapy along the route of mid-mountain natural park of Nalchik resort combined with exercise therapy and group psychotherapy in park curative grounds and nitrogen thermal baths. Assessment used the «Medical Research Council» (mMRC) scale, glycyrrhic acid level in blood serum, functional tests and cardiointervalography. In the main group, the abstract reports a reduction of apnea by 29,4% (p<0,01) compared with primary data, an average increase in adaptation capacity by 42,4% (p<0,01), an average improvement of physical activity by 36,2% (p<0,01), and normalization of hemodynamic parameters. It also states the result was significantly better (by 20-25%, p<0,05) compared to the treatment in the group of comparison, without naming the outcome. Duration, analysed sample size, side effects, harms and withdrawals are not reported.
- The Psychological Benefits of Forest Bathing in Individuals with Fibromyalgia and Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: A Pilot Study.2025 · no comparison group · 44 in the study
Summary
This pilot pre–post study assessed short-term psychological changes after one Forest Bathing session in adults with fibromyalgia and/or CFS/ME. Forty-four participants were recruited mainly via social media and an inclusive hiking club; all were women. The session was a 3 km silent walk lasting 3 h in a Mediterranean forest near Barcelona, with three 10 min stops for deep breathing and mindful awareness. Participants completed self-report measures about 1 h before and in the first 24 h after the session. There was no control group. The paper reports statistically significant decreases in negative affect (p < 0.001; d = 0.84), state anxiety (p < 0.001; d = 1.31), anger (p < 0.001; d = 0.84), fatigue (p = 0.009; d = 0.40), tension (p < 0.001; d = 1.05), depression (p < 0.001; d = 1.21), and fatigue levels (p = 0.003; d = 0.46), and significant increases in positive affect (p < 0.001; d = 0.85), vigor (p < 0.001; d = 0.84), friendship (p = 0.001; d = 0.44), mindfulness of body (p < 0.001; d = 0.48), and mindfulness of mind (p < 0.001; d = 0.64). Pain intensity did not differ significantly (p = 0.421; d = 0.14). The paper did not report side effects or withdrawals for harms. The authors state limitations including no control group, one session, no follow-up, only women, and possible self-selection.
- The Effectiveness of Non-Pharmacological Interventions in Treating Adolescents and Young Adults with Neuropsychiatric Symptoms of Long COVID: A Systematic Review and Meta-Analysis.2026 · systematic review
Summary
This systematic review and meta-analysis examined non-pharmacological interventions for neuropsychiatric symptoms of long COVID in adolescents and young adults aged 13–25 years. The review included seven studies; the recorded sample sizes were 17, 16, 208, 124, 22, 239, and 36 participants. Interventions included forest bathing, TTM, a neuropsychological rehabilitation program, a multidisciplinary post-COVID rehabilitation program, micro-choice based concentrated group rehabilitation, and EECP. Durations varied, and the review reported that most studies lacked a comparison group. Outcomes included mental health, anxiety, depression, fatigue, QoL, cognitive function, headaches, and insomnia. In the meta-analysis, the pooled mental health result was statistically significant (SMD 0.64, 95% CI 0.0012 to 1.2692, p<0.0497). Pooled results for fatigue (SMD 1.74, 95% CI −0.9416 to 4.4262, p=0.1307), QoL (SMD −1.34, 95% CI −5.2620 to 2.5784, p=0.2787), and cognitive function (SMD 1.05, 95% CI −2.1961 to 4.2934, p=0.2989) were not statistically significant. Individual studies reported improvements in several outcomes; Chokpaisam et al reported no statistically significant change in emotional well-being (78.35 ± 17.44 vs 81.18 ± 17.99, p=0.336), and Kvale et al reported no statistically significant difference in anxiety and depression (27.3% vs 38.2%, p=0.210). No harms or withdrawals were recorded. The authors stated limitations including cohort designs without comparison groups, no age-based subgroup analyses, small sample sizes, and heterogeneity.
- Systematic review of interventions for mental health, cognition and psychological well-being in long COVID.2024 · systematic review
Summary
This systematic review aimed to identify and synthesise publicly available research testing treatments for mental health, cognition and psychological well-being in long COVID. It included 33 documents representing 31 studies and 2477 participants recruited across four continents. The studies covered 7 psychosocial, 5 pharmaceutical, 3 natural supplement, 9 neurocognitive, 2 physical rehabilitation and 5 integrated intervention studies; 11 were RCTs, 2 non-randomised controlled trials, 10 uncontrolled trials, 7 case studies or series and 1 qualitative study. Some controlled trials reported significant group×time interactions: vortioxetine for depression and health-related QoL but not cognition; hyperbaric oxygen for total cognition and psychological distress only; high-definition transcranial direct current stimulation for cognitive and psychosocial fatigue, anxiety and QoL; and a programme combining non-invasive cognitive stimulation and guided mindfulness for mental fatigue, anxiety, depression, mood disturbance and several cognitive domains. Other trials reported no significant group×time interaction, including an adaptogen formulation and the ReCOVERY app. Many uncontrolled studies reported significant prepost improvements, but the authors state these cannot be definitively associated with treatment without a control group. Counts of people who worsened or stopped and side-effect counts were not reported in the recorded data; the authors note many studies did not report adverse events.